Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

As the first first Novartis viral vector production facility in Europe, it significantly expands Novartis' research and ...

While working as a financial analyst at NCR and then Novartis, his aspirations were to become CFO and use his financial expertise as an avenue to help people. It was then a wise mentor who ...